Dermapharm Holding SE
Dermapharm Holding Waste Data Preview
In 2023, Dermapharm Holding conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
Insights into Dermapharm Holding’s Generation of Hazardous and Non-Hazardous Waste
In 2023, Dermapharm Holding generated a total of 8,033 metric tonnes of waste.
Of this amount, 2.55% of Dermapharm Holding's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 97.46% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Dermapharm Holding’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How Dermapharm Holding reduced the environmental impact of its waste?
Since 2018, Dermapharm Holding's total waste generation increased by 21.6%, including a 57.94% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, Dermapharm Holding reduced the hazardousness of its waste by 22.31%, with a further 9.24% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.
Overall, Dermapharm Holding is generating more waste but has significantly reduced the share of hazardous materials, suggesting a partial decoupling of volume and toxicity that could reflect more responsible inputs or enhanced treatment.